North America Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: July 09, 2025 Report Code: GDME20406CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America Cardiac Disease Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Marker Tests

The North America Cardiac Disease Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Cardiac Disease Market.
• Global corporate-level profiles of key companies operating within the North America Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiac Disease is segmented as follows –

• Cardiac Marker Tests

Reasons to Buy

The North America Cardiac Disease Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories
Beckman Coulter Inc
bioMerieux SA
F. Hoffmann-La Roche Ltd
Quidel Corp
Siemens Healthineers AG

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Cardiac Disease Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Cardiac Disease Market, North America 9

3.1 Cardiac Disease Market, North America, Revenue ($m), 2018-2033 9

3.2 Cardiac Disease Market, North America, Revenue ($m), 2018-2033 10

3.3 Cardiac Disease Market, North America, Volume (Units), 2018-2033 11

3.4 Cardiac Disease Market, North America, Volume (Units), 2018-2033 12

3.5 Cardiac Disease Market, North America, Company Share by Revenue ($m), 2024 14

4 Cardiac Disease Market, Canada 15

4.1 Cardiac Disease Market, Canada, Revenue ($m), 2018-2033 15

4.1.1 Cardiac Marker Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 16

4.2 Cardiac Disease Market, Canada, Volume (Units), 2018-2033 18

4.2.1 Cardiac Marker Tests Market, Canada, Volume (Units), by Segment, 2018-2033 20

4.3 Cardiac Disease Market, Canada, Average Price ($), 2018-2033 23

4.4 Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2024 24

5 Cardiac Disease Market, United States 25

5.1 Cardiac Disease Market, United States, Revenue ($m), 2018-2033 25

5.1.1 Cardiac Marker Tests Market, United States, Revenue ($m), by Segment, 2018-2033 26

5.2 Cardiac Disease Market, United States, Volume (Units), 2018-2033 28

5.2.1 Cardiac Marker Tests Market, United States, Volume (Units), by Segment, 2018-2033 30

5.3 Cardiac Disease Market, United States, Average Price ($), 2018-2033 33

5.4 Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024 34

6 Cardiac Disease Market, Mexico 35

6.1 Cardiac Disease Market, Mexico, Revenue ($m), 2018-2033 35

6.1.1 Cardiac Marker Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 36

6.2 Cardiac Disease Market, Mexico, Volume (Units), 2018-2033 38

6.2.1 Cardiac Marker Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 40

6.3 Cardiac Disease Market, Mexico, Average Price ($), 2018-2033 42

6.4 Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2024 43

7 Overview of Key Companies in North America Cardiac Disease Market 44

7.1 F. Hoffmann-La Roche Ltd 44

7.1.1 Company Overview 44

7.2 Abbott Laboratories 44

7.2.1 Company Overview 44

7.3 Beckman Coulter Inc 44

7.3.1 Company Overview 44

7.4 Quidel Corp 45

7.4.1 Company Overview 45

7.5 Siemens Healthineers AG 45

7.5.1 Company Overview 45

7.6 bioMerieux SA 45

7.6.1 Company Overview 45

8 Cardiac Disease Market Pipeline Products 46

9 Recent Developments 52

9.1 Corporate Communications 52

9.1.1 Mar 03, 2025: Pulnovo secures $100m to advance clinical trials and business expansion 52

9.2 Government and Public Interest 52

9.2.1 Feb 11, 2025: New Implant May Help Patients Regenerate Their Own Heart Valves 52

9.3 Other Significant Developments 53

9.3.1 Oct 09, 2024: Heart Health for All: How We Can Improve Access to Cardiac Care around the Globe 53

9.3.2 Oct 08, 2024: Amwell Expands Clinical Programs Portfolio to Include Hello Heart Cardiovascular Health Risk Management Solution 54

9.4 Product News 55

9.4.1 Jun 09, 2025: Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of Its FIH Study 55

9.4.2 Apr 28, 2025: Simple Blood Test Could Better Predict Heart Disease Risk 56

9.4.3 Feb 28, 2025: Allegheny General Hospital First in Western PA to Participate in Clinical Trial Using Artificial Intelligence to Detect Deep Vein Thrombosis in Cardiac Patients 57

9.4.4 Jan 28, 2025: New Data Finds 31% of Working Americans and Their Families Have a Cardiac Disorder 58

9.4.5 Jan 09, 2025: Peerbridge Health Unveils Cor-Insight Trial To Validate Revolutionary Ai-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring 58

9.4.6 Dec 16, 2024: Streamlining Analysis of Ion Channel in Vitro Assays Data to Support Clinical Cardiac Safety Decision-Making 59

9.4.7 Sep 30, 2024: New Wearable Laser Device Monitors Brain Blood Flow to Gauge Stroke Risk 61

9.4.8 Aug 20, 2024: Brigham Researchers Use AI Tools to Uncover Connections Between Radiotherapy for Lung Cancer and Heart Complications 62

9.4.9 Aug 19, 2024: American Chemical Society : Improving Access to Heart-Failure Screening with Saliva 63

9.4.10 Jun 27, 2024: SoftWave TRT Affiliate Study Featured in Prominent Medical Journal 64

9.5 Strategy And Business Planning 65

9.5.1 Dec 18, 2024: Medera’s Novoheart Enters Into Transformative Partnership With Curi Bio 65

9.5.2 Jul 29, 2024: TELUS and University of Ottawa Heart Institute partner to boost emergency cardiac care efficiency with smartphone app 65

9.5.3 Jun 27, 2024: Elucid Moves into New Headquarters in Preparation for Commercial Launch 66

10 Appendix 68

10.1 Research Methodology 69

10.1.1 Coverage 69

10.1.2 Secondary Research 69

10.1.3 Primary Research 69

10.1.4 Market Modeling and Forecasting 70

10.1.5 Company Share Analysis 71

10.1.6 Benchmarking 72

10.2 GlobalData Consulting 73

10.3 Contact Us 73

10.4 Disclaimer 73

Table

Table 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 9

Table 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2018-2033 10

Table 3: Cardiac Disease Market, North America, Volume (Units), 2018-2033 11

Table 4: Cardiac Disease Market, North America, Volume (Units), 2018-2033 13

Table 5: Cardiac Disease Market, North America, Company Share by Revenue ($m), 2024 14

Table 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2018-2033 15

Table 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 17

Table 8: Cardiac Disease Market, Canada, Volume (Units), 2018-2033 19

Table 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2018-2033 21

Table 10: Cardiac Disease Market, Canada, Average Price ($), 2018-2033 23

Table 11: Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2024 24

Table 12: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033 25

Table 13: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 27

Table 14: Cardiac Disease Market, United States, Volume (Units), 2018-2033 29

Table 15: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033 31

Table 16: Cardiac Disease Market, United States, Average Price ($), 2018-2033 33

Table 17: Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024 34

Table 18: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2018-2033 35

Table 19: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 37

Table 20: Cardiac Disease Market, Mexico, Volume (Units), 2018-2033 39

Table 21: Cardiac Marker Tests Market, Mexico, Volume (Units), 2018-2033 41

Table 22: Cardiac Disease Market, Mexico, Average Price ($), 2018-2033 42

Table 23: Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2024 43

Table 27: Cardiac Disease Market Pipeline Products 46

Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 70

Figures

Figure 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 9

Figure 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2018-2033 10

Figure 3: Cardiac Disease Market, North America, Volume (Units), 2018-2033 11

Figure 4: Cardiac Disease Market, North America, Volume (Units), 2018-2033 12

Figure 5: Cardiac Disease Market, North America, Company Share (%), 2024 14

Figure 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2018-2033 15

Figure 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 16

Figure 8: Cardiac Disease Market, Canada, Volume (Units), 2018-2033 18

Figure 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2018-2033 20

Figure 10: Cardiac Disease Market, Canada, Company Share (%), 2024 24

Figure 11: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033 25

Figure 12: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 26

Figure 13: Cardiac Disease Market, United States, Volume (Units), 2018-2033 28

Figure 14: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033 30

Figure 15: Cardiac Disease Market, United States, Company Share (%), 2024 34

Figure 16: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2018-2033 35

Figure 17: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 36

Figure 18: Cardiac Disease Market, Mexico, Volume (Units), 2018-2033 38

Figure 19: Cardiac Marker Tests Market, Mexico, Volume (Units), 2018-2033 40

Figure 20: Cardiac Disease Market, Mexico, Company Share (%), 2024 43

North America Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests in real time.

Access a live North America Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports